Si-Bone

Yahoo Finance • 10 days ago

Galvanize Therapeutics Appoints Laura Francis to its Board of Directors

REDWOOD CITY, Calif., Nov. 24, 2025 /PRNewswire/ -- Galvanize ("Galvanize") Therapeutics, Inc., a commercial-stage medical technology company pioneering pulsed electric field (PEF) therapies for oncology and chronic lung disease, today ann... Full story

Yahoo Finance • 16 days ago

SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025

SANTA CLARA, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Piper Sandle... Full story

Yahoo Finance • 23 days ago

SI-BONE Inc. Q3 Loss Declines

(RTTNews) - SI-BONE Inc. (SIBN) reported Loss for third quarter of -$4.57 million The company's bottom line totaled -$4.57 million, or -$0.11 per share. This compares with -$6.58 million, or -$0.16 per share, last year. The company's re... Full story

Yahoo Finance • 23 days ago

SI-BONE outlines 18%–20% revenue growth target for 2025 with platform expansion, eyes positive free cash flow in 2026

Earnings Call Insights: SI-BONE, Inc. (SIBN) Q3 2025 MANAGEMENT VIEW * Laura Francis, CEO, reported "another quarter of robust revenue growth, achieved sustained adjusted EBITDA profitability and reached a major milestone in delivering... Full story

Yahoo Finance • 24 days ago

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance

Delivered ~21% worldwide revenue growth, ~5% adjusted EBITDA margin, and positive cash from operating activities in the quarter Third Quarter 2025 Financial Highlights (allcomparisons are to the prior year period) Worldwide revenue of $4... Full story

Yahoo Finance • last month

SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025

SANTA CLARA, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the third quarter of 2025 afte... Full story

Yahoo Finance • 3 months ago

KLIC Crosses Above Average Analyst Target

In recent trading, shares of Kulicke & Soffa Industries, Inc. (Symbol: KLIC) have crossed above the average analyst 12-month target price of $40.60, changing hands for $41.13/share. When a stock reaches the target an analyst has set, the... Full story

Yahoo Finance • 3 months ago

SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025

SANTA CLARA, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Morgan Stanl... Full story

Yahoo Finance • 4 months ago

Factbox-Russian energy export disruptions since start of Ukraine war

(Reuters) -When U.S. President Donald Trump meets Russian President Vladimir Putin on Friday, one of his bargaining chips to encourage Putin to make progress toward a ceasefire in Ukraine will be to ease U.S. sanctions on Russia’s energy i... Full story

Yahoo Finance • 4 months ago

SI-BONE’s SWOT analysis: stock poised for growth amid market challenges

SI-BONE, Inc. (NASDAQ:SIBN), a medical device company specializing in minimally invasive solutions for sacroiliac joint disorders, has been making significant strides in the orthopedic sector. The company’s innovative approach to addressin... Full story

Yahoo Finance • 4 months ago

SI-BONE stock price target reiterated at $25 by Cantor Fitzgerald

Investing.com - Cantor Fitzgerald has reiterated an Overweight rating and $25.00 price target on SI-BONE Inc. (NASDAQ:SIBN) following the company’s second-quarter 2025 financial results. According to InvestingPro data, analyst targets for... Full story

Yahoo Finance • 4 months ago

Dunn, director at Si-Bone, sells $5,090 in SIBN stock

Jeffrey W. Dunn, a director at SI-BONE, Inc. (NASDAQ:SIBN), sold 293 shares of common stock on August 4, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The transaction comes as the medical device company’s... Full story

Yahoo Finance • 4 months ago

SI-BONE raises 2025 revenue guidance to $195M-$198M with accelerated cash flow milestones

Earnings Call Insights: SI-BONE, Inc. (SIBN) Q2 2025 MANAGEMENT VIEW * CEO Laura A. Francis highlighted that "We had a record number of U.S. physicians perform our procedures this quarter, reinforcing the expanding reach and clinical a... Full story

Yahoo Finance • 4 months ago

SI-BONE INC (NASDAQ:SIBN) Posts Mixed Q2 2025 Earnings with Revenue Slight Miss but EPS Beat Drives Positive Market Reaction

SI-BONE INC (NASDAQ:SIBN [https://www.chartmill.com/stock/quote/SIBN/profile]) REPORTS Q2 2025 EARNINGS: MIXED RESULTS BUT MARKET REACTION POSITIVE SI-BONE INC released its second-quarter 2025 financial results, delivering a mixed perform... Full story

Yahoo Finance • 4 months ago

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 Guidance

Second Quarter 2025 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $48.6 million, representing growth of 21.7%U.S. revenue of $46.4 million, representing growth of 22.8%Gross margin of 79.8%, repr... Full story

Yahoo Finance • 4 months ago

SI-BONE To Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025

SANTA CLARA, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Canaccord Ge... Full story

Yahoo Finance • 5 months ago

SI-BONE To Report Second Quarter 2025 Financial Results on August 4, 2025

SANTA CLARA, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the second quarter of 2025 aft... Full story

Yahoo Finance • 5 months ago

Si-Bone SVP Pisetsky sells $57k in shares

Michael A. Pisetsky, SVP, Ops & Adm/Chief Legal Ofr at SI-BONE, Inc. (NASDAQ:SIBN), sold 3,127 shares of common stock on July 2, 2025, for approximately $57,202. The sales were executed in multiple transactions at prices ranging from $18.0... Full story

Yahoo Finance • 5 months ago

SI-BONE's SWOT analysis: medtech firm's stock poised for growth amid challenges

SI-BONE, Inc. (NASDAQ:SIBN), a medical device company specializing in minimally invasive surgery for the sacroiliac joint, has been garnering attention from investors and analysts alike. The company’s flagship product, the iFuse Implant Sy... Full story

Yahoo Finance • 5 months ago

Russia's spy agency says Serbia sold ammunition to Ukraine via Bulgaria, Czech Republic

BELGRADE (Reuters) -Russia accused Serbia on Monday of selling artillery ammunition to Ukraine through intermediaries in Eastern Europe, making the second such allegation in a month against its traditional Balkan ally. In a statement post... Full story